National Health Investors, Inc.’s recent filing unveils that its Director SWAFFORD CHARLOTTE A acquired Company’s shares for reported $0.59 million on Feb 27 ’24. In the deal valued at $58.69 per share,10,000 shares were bought. As a result of this transaction, SWAFFORD CHARLOTTE A now holds 110,185 shares worth roughly $7.23 million.
Then, Jobe James R bought 1,000 shares, generating $51,398 in total proceeds. Upon buying the shares at $51.40, the Director now owns 14,979 shares.
BMO Capital Markets upgraded its National Health Investors, Inc. [NHI] rating to an Outperform from a a Market perform in a research note published recently. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who increased its forecast for the stock in late February from “an Equal weight” to “an Overweight”. Wedbush also remained covering NHI and has increased its forecast on February 26, 2024 with a “an Outperform” recommendation from previously “Neutral” rating. Deutsche Bank started covering the stock on January 30, 2024. It rated NHI as “a Buy”.
Price Performance Review of NHI
On Tuesday, National Health Investors, Inc. [NYSE:NHI] saw its stock jump 2.18% to $65.65. Over the last five days, the stock has gained 4.11%. National Health Investors, Inc. shares have risen nearly 17.55% since the year began. Nevertheless, the stocks have risen 33.16% over the past one year. While a 52-week high of $65.23 was reached on 05/07/24, a 52-week low of $48.51 was recorded on 02/07/24. SMA at 50 days reached $60.73, while 200 days put it at $54.91. A total of 0.31 million shares were traded, compared to the trading of 0.21 million shares in the previous session.
Levels Of Support And Resistance For NHI Stock
The 24-hour chart illustrates a support level at 64.57, which if violated will result in even more drops to 63.50. On the upside, there is a resistance level at 66.41. A further resistance level may holdings at 67.18. The Relative Strength Index (RSI) on the 14-day chart is 72.48, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.75, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 6.90%. Stochastics %K at 90.34% indicates the stock is a selling.
The most recent change occurred on October 03, 2023 when Wedbush began covering the stock and recommended ‘”a Neutral”‘ rating along with a $54 price target.
